Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis. [electronic resource]
Producer: 20160930Description: 1266-73 p. digitalISSN:- 1445-5994
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Hydroxychloroquine -- administration & dosage
- Immunosuppressive Agents -- administration & dosage
- Isoxazoles -- administration & dosage
- Leflunomide
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Prospective Studies
- Remission Induction
- Sulfasalazine -- administration & dosage
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.